SLC9A1 and Glomerular sclerosis: The present study demonstrates that AGEs ex vivo or in vivo cause glomerular sclerosis and renal dysfunction, which is abrogated by NHE1 inhibition, blockage of AGEs receptor, and suppression of oxidative stress.